Tiemessen, M.M.; Solforosi, L.; Dekking, L.; Czapska-Casey, D.; Serroyen, J.; Sullivan, N.J.; Volkmann, A.; Pau, M.G.; Callendret, B.; Schuitemaker, H.;
et al. Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels. Vaccines 2022, 10, 1263.
https://doi.org/10.3390/vaccines10081263
AMA Style
Tiemessen MM, Solforosi L, Dekking L, Czapska-Casey D, Serroyen J, Sullivan NJ, Volkmann A, Pau MG, Callendret B, Schuitemaker H,
et al. Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels. Vaccines. 2022; 10(8):1263.
https://doi.org/10.3390/vaccines10081263
Chicago/Turabian Style
Tiemessen, Machteld M., Laura Solforosi, Liesbeth Dekking, Dominika Czapska-Casey, Jan Serroyen, Nancy J. Sullivan, Ariane Volkmann, Maria Grazia Pau, Benoit Callendret, Hanneke Schuitemaker,
and et al. 2022. "Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels" Vaccines 10, no. 8: 1263.
https://doi.org/10.3390/vaccines10081263
APA Style
Tiemessen, M. M., Solforosi, L., Dekking, L., Czapska-Casey, D., Serroyen, J., Sullivan, N. J., Volkmann, A., Pau, M. G., Callendret, B., Schuitemaker, H., Luhn, K., Zahn, R., & Roozendaal, R.
(2022). Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels. Vaccines, 10(8), 1263.
https://doi.org/10.3390/vaccines10081263
